RV

Ralf-Holger Voss

JM Johannes Gutenberg-Universität Mainz: 3 patents #17 of 93Top 20%
BG Biontech Cell & Gene Therapies Gmbh: 2 patents #6 of 14Top 45%
GG Ganymed Pharmaceuticals Gmbh: 2 patents #25 of 49Top 55%
📍 Ingelheim am Rhein, DE: #80 of 330 inventorsTop 25%
Overall (All Time): #704,868 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
11702631 Antigen receptors and uses thereof Ugur Sahin, Petra OEHM, Matthias BIRTEL, Janina Caspar 2023-07-18
11345731 Claudin-6-specific immunoreceptors and t cell epitopes Ugur Sahin, Ozlem Tureci, Petra Simon, Tana Omokoko, Holger Hoff +3 more 2022-05-31
10370423 Claudin-6-specific immunoreceptors and T cell epitopes Ugur Sahin, Ozlem Tureci, Petra Simon, Tana Omokoko, Holger Hoff +3 more 2019-08-06
9624292 Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds Shao-An Xue, Matthias Theobald, Hans Stauss 2017-04-18
9376482 Method for improving the specific effector function of single-chain antigen-recognizing genetic constructs (scARC) through murinization thereof Matthias Theobald, Ratna Sari Intan Pöndl, Renate Engel, Simone Thomas 2016-06-28
9062127 Method for rational mutagenesis of α/βT-cell receptors and correspondingly mutated MDM2-protein specific α/βT-cell receptors Theobald Matthias 2015-06-23
7871817 Method for rational mutagenesis of α/β t-cell receptors and correspondingly mutated mdm2-protein specific α/β t-cell receptors Theobald Matthias 2011-01-18